- Home
- WIMI vs BOLD Comparison
WIMI vs BOLD Comparison
Compare WIMI & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- BOLD
- Stock Information
- Founded
- WIMI 2015
- BOLD 2018
- Country
- WIMI China
- BOLD United States
- Employees
- WIMI 107
- BOLD 64
- Industry
- WIMI Computer Software: Prepackaged Software
- BOLD
- Sector
- WIMI Technology
- BOLD
- Exchange
- WIMI Nasdaq
- BOLD Nasdaq
- Market Cap
- WIMI 23.9M
- BOLD 24.4M
- IPO Year
- WIMI 2020
- BOLD 2024
- Fundamental
- Price
- WIMI $3.53
- BOLD $1.17
- Analyst Decision
- WIMI
- BOLD Buy
- Analyst Count
- WIMI 0
- BOLD 3
- Target Price
- WIMI N/A
- BOLD $4.00
- AVG Volume (30 Days)
- WIMI 7.6M
- BOLD 283.9K
- Earning Date
- WIMI 01-01-0001
- BOLD 08-11-2025
- Dividend Yield
- WIMI N/A
- BOLD N/A
- EPS Growth
- WIMI N/A
- BOLD N/A
- EPS
- WIMI N/A
- BOLD N/A
- Revenue
- WIMI $84,137,968.00
- BOLD N/A
- Revenue This Year
- WIMI N/A
- BOLD N/A
- Revenue Next Year
- WIMI N/A
- BOLD N/A
- P/E Ratio
- WIMI N/A
- BOLD N/A
- Revenue Growth
- WIMI 19.25
- BOLD N/A
- 52 Week Low
- WIMI $0.27
- BOLD $1.00
- 52 Week High
- WIMI $2.92
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- WIMI 60.88
- BOLD N/A
- Support Level
- WIMI $2.73
- BOLD N/A
- Resistance Level
- WIMI $3.09
- BOLD N/A
- Average True Range (ATR)
- WIMI 0.26
- BOLD 0.00
- MACD
- WIMI 0.15
- BOLD 0.00
- Stochastic Oscillator
- WIMI 83.58
- BOLD 0.00
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.